SAM
LAB icon

Senzar Asset Management’s Standard BioTools LAB Stock Holding History

Senzar Asset Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-310,587
Closed -$2.52M – 44
2015
Q3 		$2.52M Buy
+310,587
New +$4.89M 0.37% 32

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Senzar Asset Management's LAB Position: Q4 2015 in Review

Senzar Asset Management sold out of Standard BioTools (LAB) in Q4 2015, closing a stake of 310,587 shares — an estimated $2.52M sold.

Senzar Asset Management first reported a position in LAB in Q3 2015 and held it in 1 quarter. The position peaked at $2.52M in Q3 2015. 106 funds tracked by Wall St. Rank hold LAB as of Q4 2015.

  • Senzar Asset Management reported no remaining Standard BioTools position as of Q4 2015 after selling out during the quarter.
  • Senzar Asset Management sold 310,587 Standard BioTools shares in Q4 2015, an estimated $2.52M.
  • Senzar Asset Management first reported a position in Standard BioTools in Q3 2015 and held it in 1 quarter.
  • Senzar Asset Management's Standard BioTools position peaked at $2.52M in Q3 2015.
  • 106 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2015.

Based on Senzar Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.